We are live on
!
Find out more
RSCM
Rail-Splitter Capital Management Portfolio holdings
AUM
$89.4M
1-Year Est. Return
15.13%
This Fund
S&P 500
This Quarter
Est. Return
+13.95%
1 Year Est. Return
+15.13%
3 Year Est. Return
+64.07%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$327M
AUM Growth
+$22.9M
(+7.5%)
Cap. Flow
-$8.69M
Cap. Flow
% of AUM
-2.66%
Top 10 Holdings %
Top 10 Hldgs %
39.03%
Holding
45
New
9
Increased
15
Reduced
10
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$11.7M |
| 2 |
Dollar Tree
DLTR
|
+$10.4M |
| 3 |
Sherwin-Williams
SHW
|
+$9.04M |
| 4 |
Cboe Global Markets
CBOE
|
+$9.01M |
| 5 |
AbbVie
ABBV
|
+$8.87M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$10.8M |
| 2 |
Tenet Healthcare
THC
|
+$8.88M |
| 3 |
Medtronic
MDT
|
+$8.66M |
| 4 |
AKRX
Akorn Inc
AKRX
|
+$7.93M |
| 5 |
ZU
ZULILY INC CLASS A COMMON STOCK
ZU
|
+$6.66M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.22% |
| 2 | Healthcare | 16.39% |
| 3 | Consumer Discretionary | 15.12% |
| 4 | Industrials | 11.12% |
| 5 | Financials | 6.7% |
Similar funds
KC
VM
QGI
ZC
TF
SAM
NA
NCIM
Rail-Splitter Capital Management's Q4 2014 Portfolio in Review
As of Q4 2014, Rail-Splitter Capital Management held 45 positions worth $327M, up 7.5% from $304M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Rail-Splitter Capital Management's Q4 2014 filing shows 9 new, 15 increased, 10 reduced and 11 closed positions. Its largest new stake was COVIDIEN PLC COM SHS NEW (IRELAND): 121,970 shares worth $12.5M. The largest sale was Merck, an estimated $10.8M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Rail-Splitter Capital Management's largest Q4 2014 buy was COVIDIEN PLC COM SHS NEW (IRELAND): 121,970 shares worth $12.5M.
- Rail-Splitter Capital Management added most to Cognizant in Q4 2014, an estimated $3.02M increase.
- Rail-Splitter Capital Management's biggest Q4 2014 reduction was Gilead Sciences, cutting an estimated $3.97M.
- Rail-Splitter Capital Management fully exited Merck in Q4 2014, selling an estimated $10.8M.
- Rail-Splitter Capital Management's ten largest holdings make up 39% of its $327M portfolio in Q4 2014.
- Rail-Splitter Capital Management opened 9 new positions and closed 11 in Q4 2014.
- Rail-Splitter Capital Management's portfolio value rose 7.5% quarter-over-quarter to $327M.
Based on Rail-Splitter Capital Management's 13F filing for Q4 2014, filed 15 Jan 2015.